Luis M. Ruilope

TL;DR: Evidence based on recent studies showing that losartan and irbesartan can prevent the development of overt diabetic nephropathy in microalbuminuric type 2 diabetic patients as well as slow the velocity of progression to end-stage renal disease in patients with overt type 2 Diabetes mellitus is supported.

TL;DR: In this article, the authors considered the effect of renal function on the risk of cardiovascular morbidity and mortality in hypertensive patients and suggested that parameters indicating the existence of an alteration in renal function (increased serum creatinine, proteinuria, and microalbuminuria) are independent predictors for an increased cardiovascular risk.

TL;DR: Steno Diabetes Center Copenhagen, Herlev, Denmark Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark Swiss Eye Institute, Rotkreuz, and Berner Augenklinik, Bern, Switzerland Department of Ophthalmology, Inselspital and University of Bern, Bern as mentioned in this paper .

TL;DR: In this paper, the authors discuss the CKD 'blind spot' concept and how it may facilitate a holistic approach to CKD and cardiovascular disease prevention and implement the call for albuminuria screening implicit in current guidelines.

TL;DR: In summary, physical exercise appears as an effective option to reduce BP in patients with RH, although more research is needed to confirm these findings as well as to determine the most effective exercise characteristics.